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Summary 
Longevity is tightly linked across evolution to the maintenance of genomic stability. Centenarians 
are long-living subjects who reach the extreme limits of human lifespan, while escaping the 
inflammatory age-related diseases. Current literature underpins that genomic damage elicits 
inflammation by engaging cytoplasmic sensors via the misplacement of nucleic acids (including 
RNA:DNA hybrids) outside the nucleus. Here, we report that high genomic stability (i.e. preserved 
telomere length) and blunted DNA-damage-induced inflammation characterize centenarian’s 
fibroblasts. This molecular make-up is associated with reduced amounts of cytoplasmic RNA:DNA 
hybrids. These cells convey high levels of the RNA:DNA degrading enzyme subunit RNAseH2C, 
whose knock-down up-regulates inflammatory mediators. The RNAseH2C locus is hypo-
methylated in centenarian’s cells, hyper-methylated in senescent cells, and in atherosclerotic 
plaques and cancer tissues. Noteworthy, RNAseH2C expression and anti-inflammatory phenotype 
can be elicited in different cell types exposed to Extracellular Vesicles isolated from centenarian’s 
cell cultures. These data provide evidence on the molecular mechanisms that allow centenarians to 
escape the deleterious effects of inflamm-aging and to avoid inflammatory age-related diseases.  
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Introduction  
Human longevity represents the capability of exceptional individuals to reach the extreme limits of 
human lifespan, while avoiding age-related diseases, such as atherosclerosis and cancer [1]. A 
common feature of age-related diseases is the activation of inflammatory pathways that recalls the 
systemic pro-inflammatory status that develops with age, named inflamm-aging [2]. At cellular 
level, inflammatory activation has been linked to DNA damage, a phenomenon which is epitomized 
in cell senescence, a state of permanent growth arrest in which a pro-inflammatory secretome is 
sustained by DNA-damage response (DDR) [3]. Speculatively, this phenomenon is likely to 
contribute to inflamm-aging [4]. Recently, DDR-induced inflammation has been linked to the 
misplacement of DNA into the cytoplasm as a consequence of genomic damage. [5]. In the 
cytoplasm, nucleic acids are recognized by evolutionary-conserved innate immunity sensors that 
ignite inflammation and type-I interferon (IFN) response [6]. A crucial role of such cytoplasmic 
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machinery has been recognized in senescent cells [7]. A particular kind of DNA damage-induced 
nucleic acids that can be misplaced into the cytoplasm are RNA:DNA hybrids [5,8]. These nucleic 
acids are highly capable to elicit inflammation and IFN response [9], and accumulate in cells 
carrying mutations in genes involved in the DNA repair mechanisms or lacking the RNA:DNA 
hybrids degrading machinery i.e. RNAseH2 [10, 11]. Genetic defects (i.e. RNAseH2C mutations) 
that lead the accumulation of RNA:DNA hybrids causes early-onset inflammatory diseases (fatal 
auto-inflammatory diseases), and are likely linked to the pathogenesis of age-related auto-immune 
diseases (e.g. systemic lupus erythematosus and psoriasis) [12, 13]. Current literature is concordant 
in considering that degradation of misplaced RNA:DNA hybrids is a crucial physiologic 
phenomenon to preserve normal cell functioning [12]. Noteworthy, cells defective for such 
machinery are not only sources of inflammatory mediators because of nucleic acid accumulation in 
the cytoplasm, but also accumulate RNA:DNA hybrids in the nucleus, a phenomenon that cause 
genomic instability and telomere derangement, thus creating the premises to further ignite 
inflammation and promoting cell senescence [11, 14]. Centenarians are a very informative model of 
longevity to understand factors that protect from age-related pathologies. Indeed, centenarians 
escape the majority of age-related diseases and avoid the detrimental effects of inflamm-aging [1]. 
A possible explanation for this phenomenon stands in their molecular setup that may restrain the 
activation of the innate immunity/inflammation in response to the accumulation of stress response 
byproducts [15]. In our previous investigation we showed that centenarians are endowed with 
highly efficient DNA repair capacity mainly due to the activation of 53BP1-dependent Non 
Homologous End Joining (NHEJ) [16]. Moreover, we previously reported that centenarians are 
endowed of well-preserved telomeres, an established marker of genomic integrity [17]. Here, we 
hypothesize that centenarians may be endowed with a molecular setting that allows them to 
maintain genomic stability while avoiding the activation of IFN/inflammatory response that 
accompanies DNA damage and occurs in senescent and stressed cells [3, 18]. To this purpose we 
measured the level of interleukin-6 (IL-6), as the most representative cytokine involved in aging 
and inflamm-aging (“the cytokine for gerontologist”) [19], whose level associates with mortality 
and morbidity in aging and in the age-related pathologies, such as atherosclerosis and cancer [20]. 
We also measured IFN, which is a major mediator of in vitro senescence and elicits systemic 
progeric features in mice [21]. We then assessed the level of cytoplasmic RNA:DNA hybrids in 
fibroblasts of people of different ages and the expression of the cognate degrading enzyme 
RNAseH2 [12]. Finally, owing to the capability of extracellular vesicles (EV) to modulate IFN [22] 
and to systemically affect the inflammatory response [23] [24], we assessed the contribution of EV 
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in the capability of centenarian’s fibroblasts to propagate their longevity-promoting molecular setup 
to recipient cells.  
Materials and Methods 
Cell cultures 
Primary dermal fibroblasts (DF, Supplementary Table 1) were obtained from healthy young (18-
40 years), old (58-98 years), and centenarian (>99 years) subjects. DF were cultured in 10% FCS 
DMEM (Euroclone, Milan, Italy). All the experiments were performed between the 3rd and 6th in 
vitro passage. DF were collected upon signed informed consent. The study was approved by the 
local Ethics Committee (S.Orsola-Malpighi Hospital Prot. n. 2006061707, amendment 08/11/2011; 
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Prot. n. 2035, amendment 
30/11/2011; University of Calabria 9/9/2004 amendment on 24/11/2011). Early passages and 
senescent human embryonic diploid lung fibroblasts were cultured as previously described [25]. 
THP1 cells were maintained in 20% FCS RPMI 1640 medium. Cells were seeded in 24-well 
plates at a density of 500.000 cells/ml. For M1-M2 monocyte polarization assay, THP1 were 
exposed to 1x103 CD9+ EV/cell for 72h. MCF-7 cells were cultured in 10% RPMI 1640 medium. 
MCF-7 MS were generated by seeding single cell suspension (1-5x 10^3 cells per well) in low 
attachment plates filled with Mammoculttm (Stem cell technologies, Vancouver, CA) and assessed 
at day 7 [26]. HUVECs were cultured as previously described (Prattichizzo et al., 2016) [27].  
Exposure of DF to DNA damaging agents 
DF were exposed to a single radiation dose of 7.5Gy using the linear acceleration Elekta Synergy 
Platform system (Elekta Oncology Systems, Stockholm, Sweden) as previously described [28]. 
DNA damage was evaluated 72h after treatment. Doxorubicin (Sigma, St Louis, MO) was used at a 
concentration of 5µM for 24h.  
Comet Assay 
The assay was performed according to the manufacturer’s protocol (Comet assay, Trevigen, 
Gaithersburg, MD). Briefly, at the end of the treatments, 5x105 cells were suspended in LMA 
garose (at 37°C) at a ratio of 1:10 (v/v), and 75 µl were immediately transferred onto the comet 
slide. The slides were immersed for 1 hr at 4°C in a lysis solution, washed in the dark for 1 hr at 
room temperature in alkaline solution, then electrophoresed for 30 min at 20V. Slides were 
immersed twice in dH2O for 5 minutes each, then dipped in 70% ethanol and stained with the Silver 
Staining Kit (Trevigen). The extent of DNA damage was evaluated quantitatively by Olympus IX51 
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microscope 10x, Olympus Corporation, Tokyo, Japan by scoring at least 100 nucleoids of different 
categories, using the free software Cell Profiler (version 2.1.1). Percentage of DNA in tail for 
different categories of comets was expressed. 
Confocal microscopy analysis 
Cells were fixed and permeabilized with ice cold methanol for 10’ and acetone for 1’ on ice, 
blocked with 2% BSA, and incubated with primary anti-S9.6 antibody (1:100 dilution, Kerafast, 
Boston, MA, USA) and secondary goat anti-mouse Alexa Fluor 488 (1:250; Life Technologies). 
Alternatively, cells were fixed with paraformaldehyde 4% for 20 min at room temperature and 
incubated overnight at 4°C with anti Rad51 diluted 1:100 (Millipore, Milan, Italy). The confocal 
imaging was performed with a Nikon A1 confocal laser scanning microscope, equipped with a 60x, 
1.4NA objective and with 405, 488 and 561 nm laser lines. Rad51 foci were enumerated using Fiji 
(ImageJ). 
Transient gene Knock-down and over-expression 
RNAseH2C (HSS149830) and Snai2/Slug (HSS109993/109995/185949) specific siRNA, the GC 
matched content control (siSCR) were transiently transfected with lipofectamine 2000 (Life 
technologies, Carlsbad, CA, USA) following manufacturer instructions. All transfections were 
performed onto 70% confluent cells. The cells were harversted after 72h of siRNA transfection and 
stored in TRIzol® (Life technologies, Carlsbad, CA, USA). 
Real time PCR analysis 
Total RNA was extracted from cells using TRIzol® (Life technologies, Carlsbad, CA, USA). 
Taqman probes for Rad51, Snai2/Slug, IL-6, RNAseH2A/B/C, Interferon beta-1, TREX1, IL-1, 
PPRalpha, PPRgamma, RXRalpha, Alox-15, Jagged-1, IL-10, CD163, CD68 and Glucuronidase, 
were purchased from Life technologies (Carlsbad, CA, USA). Quantitative PCR analysis was 
performed on Light-Cycler using iQ software (BIORAD, Hercules, CA, USA), mRNA levels were 
calculated with 2^-ddct method. 
Telomere Length assessment 
Telomere length was measured as telomere-to-single copy gene ratio (T⁄S), using quantitative real-
time PCR as previously described [29] with some modifications. For cellular samples 5 µl aliquots 
containing 20 ng DNA and 10 µl of master mix per sample were processed. For EV samples 5 µl 
aliquots containing 0.8 ng DNA and 10 µl of master mix per sample were processed. For each 
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standard curve, one reference DNA sample was diluted serially in water by 1.68-fold dilution to 
produce 5 DNA concentrations ranging from 30 to 2 ng in 5 µl. To reduce inter-assay variability, 
the telomere and the single-copy gene (36B4) were analysed on the same plate. Primer sequences 
and concentrations for telomere and 36B4 were as previously described [29]. The thermal cycling 
profile was: (1) one cycle of 10 s at 95 °C; (2) 30 cycles of 5 s at 95 °C, 15 s at 57 °C and 20 s at 72 
°C. Measurements were performed in duplicate and reported as T⁄ S ratio relative to a calibrator 
sample (Roche, Milano, Italy) to allow comparison across runs. EV telomeric sequencies were 
quantified based on the RT-PCR CT, without the comparison with single gene copy. To date no 
single gene copy was described in EV. The real-time Chromo4 MJ Research system (Bio-Rad 
Laboratories, Hercules, CA, USA) was used for all PCRs. The coefficients of variation within 
duplicates of the telomere and single-gene assay were 2% and 1.8%, respectively. Approximately 
30% of samples were repeated on different plates to assess T/S measurement reproducibility. The 
inter-assay coefficient of variation was < 10%. All analyses were blind. The correlation coefficient 
between T⁄ S and the telomere restriction fragment was R2 = 0.88 
ELISA test  
IL-6 ELISA was performed with Quantikine ELISA kit for human IL-6 (R&D System, 
Minneapolis, MN, USA) according to manufacturer instructions. Concentrations of Maresin 1 and 
Resolvin D1 (RvD1) in cell culture supernatants were measured using commercially available 
ELISA kits (Cayman Chemical Co., Ann Arbor, MI, USA) according to manufacturer instructions.  
Western Blot analysis 
Proteins were extracted with radio-immunoprecipitation assay buffer, with the exception of γ-
H2AX extraction which was performed by adding HCl to the lysis buffer [10 mmol/L HEPES (pH 
7.9); 1.5 mmol/L MgCl2; 10 mmol/L KCl] to a final concentration of 0.2 mol/L. The following 
antibodies were used: anti-actin (C4- Santa Cruz, CA); anti-phospho-(gamma)-Histone H2AX 
(Ser139, clone JBW301, Millipore, Billerica, MA, USA); anti-Rad51, clone 3C10 (Millipore); anti-
Snai2/Slug (L40C6, Cell Signalling, Beverly, MA, USA); anti-RNASeH2C (Protein-tech, IL, USA) 
and anti-actin (clone C4, Santa Cruz, CA, USA) as loading control. 
DNA Methylation analysis 
DNA methylation of RNASEH2C locus (genomic region: chr11:65,486,750-65,487,179, 
GRCh37/hg19) was evaluated using the EpiTYPER assay (Agena Bioscience). Briefly, the EZ-96 
DNA Methylation Kit (Zymo Research Corporation) was used to perform bisulfite-conversion of 
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500 ng of genomic DNA. This treatment specifically converts unmethylated cytosines to uracils, 
while methylated cytosines remain unaffected. Ten ng of converted DNA were amplified using the 
following primers for bisulfite-converted DNA : 
RNASEH2C_F_aggaagagagATGGGGTTGAGGATAGTTTAAAAAG;RNASEH2C_R_cagtaatacg
actcactatagggagaaggctCCCAATAAAAAAACTCTTCACAACA. PCR products were then 
processed and analysed according to EpiTYPER protocol. The following Gene Expression Omnibus 
datasets were analysed for RNASEH2C methylation according to Illumina HumanMethylation450 
BeadChip array measurements: GSE40279, which includes whole-blood DNA methylation data 
from 656 healthy subjects with age ranging from 19 to 101 years; GSE46394, which includes DNA 
methylation data from 15 atherosclerotic lesion tissues and matched normal aortic tissue, plus 19 
carotid atherosclerotic samples; GSE66695, which includes DNA methylation data from 40 normal 
and 80 breast cancer samples. 
Small RNA seq analysis 
Small RNA libraries were prepared from 6 dermal fibroblast samples using TruSeq Small RNA 
Library PrepKit v2 (Illumina, RS-200-0012/24/36/48), according to manufacturer’s indications. 
Briefly, 35 ng of purified RNA were linked to RNA 3’ and 5’ adapters, converted to cDNA and 
amplified using Illumina primers containing unique indexes for each sample. Each library was 
quantified using Agilent Bioanalyzer and High Sensitivity DNA kit (Agilent, 5067-4626) and equal 
amount of libraries were pooled together. A size-selection was performed to keep fragments 
between 130-160 bp. After ethanol precipitation, the library pool was quantified with Agilent High 
Sensitivity DNA kit, diluted to 1.8 pM and sequenced using NextSeq® 500/550 High Output Kit v2 
(75 cycles) (Illumina, FC-404-2005) on Illumina NextSeq500 platform. Raw base-call data 
generated from the Illumina NextSeq 500 system were demultiplexed by Illumina BaseSpace 
Sequence Hub (https://basespace.illumina.com/home/index) and converted to FASTQ format. After 
a quality check, which was performed with FastQC tool 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/), the adapter sequences were trimmed 
using Cutadapt (http://cutadapt.readthedocs.io/en/stable/index.html). In this step, sequences shorter 
than 10 nucleotides were also removed. Read mapping was performed using STAR algorithm 
(https://www.ncbi.nlm.nih.gov/pubmed/23104886). The reference genome was constituted by 
human microRNAs sequences from the miRbase 21 database (http://www.mirbase.org/). Counts of 
raw mapped reads were obtained using the htseq-count script from the HTSeq tools (http://www-
huber.embl.de/HTSeq/doc/overview.html); raw count were further normalized using DESeq2 
bioconductor package (http://bioconductor.org/packages/release/bioc/html/DESeq2.html). Data 
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were analyzed using Genespring GX software v. 14.8 (Agilent Technologies). Differentially 
expressed miRNAs were identified using moderated t-test (FDR 10% with Benjamini-Hochberg 
correction), Principal Component Analysis and Cluster Analysis, with Manhattan correlation, were 
performed using GeneSpring GX software.  
CD9+ Exosome Isolation and phenotypization from DF supernatants 
CD9+ exosomes from young, old and centenarians DF supernatants were isolated by CD9 
immunobeads isolation kit (HansaBioMed Life Sciences Ltd; cod: HBM-BOLC-CC/20-1) 
according to manufacturer’s protocol. EVs were diluted to approximately 1 ml of PBS, loaded into 
the sample chamber of an LM10 unit (Nanosight, Malvern, UK) and three videos of either 30 or 60 
seconds were recorded of each sample. Exosomal-surface antigens were investigated with the 
MACSPlex Exosome kit (Miltenyi Biotec GmbH, Gladbach, Germany). Briefly, after isolation, 
Exosomes were diluted in MACSPlex buffer and stained according to manufacturer instructions. 
The samples were analyzed with a FACSCanto flow cytometer (Beckton Dickinson). At least 
10,000 events per sample were recorded. Data were analyzed with FACSDiva software. The median 
fluorescence values plotted in the graph were background corrected and normalized on CD63/81/9 
median signal intensity. Negative values were excluded from the plot. 
Statistical analysis  
The exact p-value calculated by un-paired t-test (two groups comparisons) and one-way ANOVA 
(>2 groups comparisons). Post-hoc t-test values were corrected for multiple comparison according 
to Bonferroni correction. The statistical analysis was performed with Graph-pad Prism 6 software. 
 
Results 
Reduced level of Interleukin-6 and high genetic stability characterize cells from centenarians. 
The first observation of our investigation regards the reduced IL-6 protein level in the supernatant 
of centenarian’s primary dermal fibroblasts (DF) compared to supernatants from aged people ones 
(Figure 1a). The finding above was confirmed by real time PCR analysis, which also conveyed 
reduced IL-6 mRNA level in DF and peripheral blood mononuclear cells (PBMC) from 
centenarians, as compared to aged people (Figure 1b). These data suggested that cells from 
centenarians are characterized by a restrained pro-inflammatory phenotype. To further confirm this 
hypothesis, we performed small RNA-seq analysis, which showed the expression of an anti-
inflammatory micro-RNA profile in centenarian’s DF (Supplementary Figure 1a) [30-34]. We 
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then tested if such a peculiar molecular setup persisted even after induction of a DNA damage: upon 
exposure to a single radiation dose of 7.5Gy, we substantiate that centenarian’s DF show a 
dramatically hampered capability to express IL-6, with respect to cells from old subjects (2 folds vs 
80 folds, Figure 1c). Similar results were observed when cells were exposed to Doxorubicine 
(Figure 1d). These data indicate that centenarian’s cells are endowed with hampered pro-
inflammatory response to damaging agents. This finding is in agreement with our previous 
observation that centenarian’s DF have a high capability to promptly repair DNA damage [16]. In 
our set of centenarian’s DF, and in agreement with our previous observations [16] we found low 
level of the DNA double strand breaks (DSB) sensor Ser139-phosphorylated γ-H2AX (Figure 2a), 
accompanied by low level of overall DNA damage measured by comet assay (Figure 2b). 
Importantly, low levels of DNA damage and Ser139-phosphorylated  γ-H2AX were persistent in 
centenarian’s DF even after 7.5Gy of gamma radiation (Figure 2c) and doxorubicine exposure 
(Figure 2d). Interestingly, we previously reported that centenarian’s DF display an up-regulation of 
the DNA damage repair protein 53BP1 [16]. 53BP1, while promoting the error-prone NHEJ 
machinery, switches-off the error-free Homologous (HR) DNA repair machinery [35]. Accordingly, 
we observed a substantial decrease of the major player of HR protein, i.e. Rad51 in centenarian’s 
DF compared to old people ones (Figure 2e). This observation was confirmed by confocal 
microscopy analysis, showing a decrease of Rad51 positive foci in centenarian’s DF even upon 
7.5Gy of gamma radiation exposure (Figure 2f). Finally, since telomeres are major source of DNA 
damage signalling and HR is a major mechanism of telomere maintenance, we assessed telomere 
length in DF by PCR analysis. In keeping with previous observations [17], we found that 
centenarian’s DF display higher than expected telomere length, being more similar to young people 
than old people ones (Figure 2g). These data show that blunted inflammatory activation in 
centenarian’s DFs is accompanied by a remarkable genomic stability. 
High level of RNAseH2C and low level of RNA:DNA hybrids are present in centenarian’s 
cells  
DNA damage is a powerful trigger of inflammation and IFN response as a consequence of the 
misplacing of nucleic acids into the cytoplasm [5, 8]. When DF from young, old and centenarians 
were assessed for the expression of IFN (and IL-6 for comparison), DF from centenarians showed a 
reduced expression of IFN, strikingly paralleling that of IL-6 (Figure 3a). Notably, IL-6 and IFN 
levels in young subjects were remarkably similar to those of centenarians (Figure 3a). A similar 
age-related trend (an up-regulation in aged people compared to young and centenarian’s cells) was 
observed for the IFN-regulated gene TREX1 (Figure 3b). RNA:DNA hybrids are processed by 
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RNAseH2 enzyme [12]. Remarkably, all three components of the RNAseH2 enzymatic complex 
were up-regulated in centenarian’s DF compared to old people (Figure 3c). In particular, the up-
regulation of RNAseH2C subunit in centenarian’s cells, was confirmed by western blot analysis 
(Figure 3c). Accordingly, the amount of RNA:DNA hybrids, assessed by confocal microscopy 
analysis, resulted reduced in the cytoplasm of centenarian’s DF, with respect to old people’s ones 
(Figure 3d). Moreover, after 7.5Gy of gamma radiation exposure, a dramatic increase of the 
amount of RNA:DNA hybrids in the cytoplasm of young and old people’s DF, but not in 
centenarian’s DF, was observed (Figure 3d). Importantly, we observed an opposite relationship 
between RNAseH2C and IL-6 expression in cells exposed to 7.5Gy of gamma radiation (Figure 3e-
f). In centenarian’s cells the transient knock-down of RNAseH2C leads to a marked dose-dependent 
increase of IL-6 and INF expression (Figure 3g). These data indicate that RNAseH2C expression 
drives the anti-inflammatory phenotype of centenarian’s cells. 
Opposite correlation between RNAseH2C locus Methylation and disease-free longevity  
Prompted by the above described results, we measured RNAseH2C expression in senescent cells, 
the best characterized model of in vitro aging [3]. A down-regulation of RNAseH2 subunits 
expression was observed in senescent primary human umbilical endothelial cells (HUVEC), in 
which a significant up-regulation of IFN was also found (Figure 4a). Accordingly, we found 
reduced RNAseH2C expression in senescent foetal lung fibroblasts [25] compared to early passage 
cells (Figure 4b). Epigenetic age-related changes are deeply involved in the aging process [36]. 
Inspired by the opposite RNASeH2C expression found in centenarians DF and senescent cells, 
DNA methylation at RNAseH2C locus was assessed by EpiTYPER assay (Figure 4c). A marked 
hypomethylation of the first 3 CpG sites of the investigated amplicon in centenarian’s DF was 
observed (Figure 4d). Accordingly, we also observed an age-related decrease of RNAseH2C 
methylation level in PBMC (assessed by the Illumina Infinium 450K platform (GSE40279)), at 
least at cg11637721 (corresponding to the CpG3 site explored by the EpiTYPER assay) (Figure 
4e). As expected, senescent lung fibroblasts displayed a higher degree of methylation in the same 
RNAseH2C sites that were hypomethylated in centenarian’s DF (Figure 4f). We thus reasoned that 
RNAseH2C gene methylation may be increased in pathologic tissues. To verify this assumption, we 
searched Gene Expression Omnibus (GEO) database for DNA methylation datasets and analyzed 
data from GSE46394 and GSE66695 (see Methods). The analysis conveyed that the RNAseH2C 
CpG site cg11637721 is hypermethylated in tissues obtained from atherosclerotic plaques (Figure 
4g) and breast cancer tissues, compared to cognate healthy ones (Figure 4h). These data indicate 
that disease-free longevity is associated with an unmethylated state of RNAseH2C locus.	
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Anti-inflammatory activity of extracellular vesicles from centenarians 
EV have been recently reported to modulate INF/inflammatory response [37, 22]. To test the role of 
EV in our experimental setting, we isolated EV from young, old and centenarian’s DF supernatants 
by anti-CD9 coated immunomagnetic beads. EV were counted by Nanosight and phenotypically 
characterized by FACS analysis (Supplementary Figure 2a). EV were then administered to 
primary DF of people of different ages, THP1 myelomonocytic and MCF-7 breast cancer cells 
(Figure 5a). We found that EV from centenarians were able to reduce IL-6 expression and to 
induce RNAseH2C in young people’s DF, as well in THP1 and MCF-7 cells (Figure 5b-c, 
Supplementary Figure 2b). In THP1 cells exposed to centenarian’s EV, we observed an over-
expression of M2-polarization markers (CD68, CD163, IL-10 and PPAR-gamma, (Figure 5d), an 
up-regulation of anti-inflammatory enzyme (Alox-15) and RXRalpha transcription factor (Figure 
5e), as well as a down-regulation of pro-inflammatory cytokines (IFN, IL-1) and PPR-alpha 
transcription factor (Figure 5f). Such an anti-inflammatory capacity of centenarian’s EV was 
confirmed by high levels of pro-resolving mediators (maresin-1 and resolvin D1) in THP1 cells 
administered with centenarian’s EV and exposed to 7.5Gy of gamma radiation (Figure 5g). Finally, 
we observed that EV from centenarians contained more than expected amounts of TTAGGG 
telomeric repeats (Figure 5j), that have long been characterized for their peculiar anti-inflammatory 
activity [38-40]. These data show the anti-inflammatory activity of centenarians EV. 
Discussion 
This paper reports the reduced inflammatory setup (low IL-6, INF and inflamma-miR 
expression) of DF from centenarians. Such exceptional individuals are the living proof that it is 
possible to reach the extreme limits of human life span by escaping the detrimental effects of major 
age-related dysfunctions and diseases [1]. These latter (e.g. atherosclerosis, diabetes and cancer), 
albeit extremely heterogeneous, share an inflammatory pathogenesis [4]. Hence, the data here 
reported suggest that the molecular setup of centenarians may allow these individuals to avoid or 
postpone inflamm-aging, i.e. the seemingly unavoidable activation of the inflammatory response 
that occurs during life [2]. Along the myriads of agents that may ignite inflammation, DNA damage 
response has emerged a crucial mechanism to explain the pro-inflammatory secretome of senescent 
cells [3]. More in general, DNA damage is associated with inflammation in a variety of physiologic 
and pathologic conditions [5, 10, 12, 18, 41]. Here we show remarkable genomic stability in cells 
from centenarians, i.e. almost absent comet tails and barely detectable levels of γ-H2AX 
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phosphorylation, even after exposure to DNA damaging agents. These peculiar features associate 
with a well-preserved telomere length. All these features extend and confirm previous reports [16, 
17], showing that centenarians are likely to be endowed with peculiar capability to repair DNA 
damage, an activity that is associated with longevity across evolution [42]. Based on the tight 
relationship between inflammation and DNA damage, the maintenance of the genome is expected to 
shelter the individuals from a variety of inflammatory diseases, and more in general to prevent or 
post-pone inflamm-aging. Recent literature shows that DNA damage-induced inflammatory and 
IFN responses depend upon the displacement of nucleic acids into the cytoplasm, where they 
engage cognate sensors [5, 8, 12, 18]. The phenomenon has been recently linked to the induction of 
the pro-inflammatory secretome of senescent cells [7]. A particular kind of DNA damage-induced 
misplaced nucleic acids are DNA:RNA hybrids [5, 8]. Here we show that cells from centenarians 
are almost devoid of cytoplasmic RNA:DNA hybrids even upon the exposure to gamma radiations. 
Accordingly, the enzyme involved in the clearance of RNA:DNA hybrids, namely RNAseH2, is 
strongly up-regulated in cells from centenarians. Then we report that the knock-down of 
RNAseH2C elicits IL-6 and IFN expression, thus demonstrating that the up-regulation of this 
enzyme plays a substantial part in the anti-inflammatory setup of centenarian’s cells. These data are 
in agreement with current literature showing that RNaseH2C mutations that impair cytoplasmic 
RNA:DNA hybrids degradation are major trigger for the inflammatory/IFN response [12]. Notably, 
RNA:DNA hybrids, albeit essential intermediates of the HR-dependent repair of telomere ends, 
must be proficiently removed to ensure genomic and telomeric stability [43]. Noteworthy, cells of 
centenarians display almost undetectable levels of Rad51 protein, the major player of HR, thus 
suggesting that they may act as HR deficient cells. This apparently paradoxical finding, perfectly 
fits with our previous observation that centenarian’s cells show the up-regulation of 53BP1, the 
major mediator of NHEJ, that switches off Rad51 expression and function [35]. In such a peculiar 
genetic background, the up-regulation of the RNAseH2 enzyme, by promoting RNA:DNA hybrid 
degradation, is likely leading to genomic stability, thus assuring telomere maintenance [44]. In this 
regard, the unbalancing of DNA-repair mechanisms towards NHEJ, associated with higher 
expression of RNAseH2C is expected to be advantageous for human longevity as it may ensure 
adequate DNA repair, while avoiding the deleterious effects of Rad51-generated RNA:DNA 
hybrids [45]. As far as the Rad51 down-regulation in centenarian’s cells, based on our previous 
observations [26], we noticed an up-regulation of Rad51 repressor SLUG, whose down-regulation 
up-regulated Rad51 mRNA level (Supplementary Figure 3a-b). Noteworthy, SLUG expression 
was also capable to up-regulate RNAseH2C expression (Supplementary Figure 3c). Thought these 
data may be considered preliminary, it may be speculated that SLUG-dependent mechanisms may 
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control DNA stability and the cognate inflammatory response in aging by modulating RNAseH2 
expression. In this regard, we provide evidence that the expression of RNAseH2C is epigenetically 
regulated. In particular, RNAseH2C is hypo-methylated in centenarians, but hyper-methylated in in 
vitro senescent cells, atherosclerotic plaques and breast cancer tissues. Notably, all these cell types 
represent pathologic conditions associated with aging and with the up-regulation of inflammatory 
response [4, 46]. Notably, our data on the positive relationship between RNAseH2C and longevity 
are reinforced by literature data showing that RNAseH-dependent RNA:DNA hybrids clearance 
extends lifespan in the yeast [47]. Notably, RNAseH2C locus (as well as IL-6 receptor) were 
identified in a recent genome-wide analysis on human longevity as potential polymorphisms that 
may explain part of the inter-individual variability in attaining healthy aging and longevity [48]. A 
major conundrum in aging studies is the relationship between cellular and organismal mechanisms 
of aging. In this paper we show that centenarian’s cells can cast anti-inflammatory signals to other 
distal cell types, such as fibroblasts, monocytes and cancer cells, via EV. Such subcellular nano-
scaled structures have been extensively characterized [23] and contain a wealth of cellular 
components, including nucleic acids [33]. In all cellular models here tested, EV isolated from 
centenarian’s DF are capable to induce RNAseH2C and reduce IL-6 expression. Seemingly, this 
phenomenon allows to conclude that the longevity-assuring molecular setup of centenarians can be 
propagated from cell to cell, and may therefore act as a systemic spreading that may counteract the 
pro-inflammatory secretome of senescent cells [4]. EV from centenarians also skew monocyte 
polarization towards the M2 phenotype which exhibits anti-inflammatory, pro-resolution and 
reparative capability [49]. These data are reinforced by our observation regarding the capability of 
EV from centenarians to up-regulate two omega 3–derived lipidic mediators, Resolvin-D1 and 
Maresin, which are tightly linked to the M2 macrophage phenotype [49, 50]. These pro-resolution 
anti-inflammatory mediators are currently regarded as molecules with powerful capability to taper 
inflammation and to promote tissue integrity and repair [50]. Noteworthy, EV from old people have 
been recently shown to induce M1-like features in monocytes [24]. Interestingly, in MCF-7 MS 
grown in vitro as 3D culture, a model for IL-6-dependent breast cancer stem cells growth [46], MS 
growth was blunted upon the administration of EV from centenarians (Supplementary Figure 4a) 
and showed also a reduced level of the IL-6 dependent MS growth factor JAG-1 (Supplementary 
Figure 4b) [46]. These data suggest that long-living individuals may escape cancer by setting-up an 
anti-inflammatory niche that halts or thwarts cancer cell growth and/or aggressiveness. Finally, we 
aimed at investigating whether the content of centenarian’s EV may account for their anti-
inflammatory activity. Unfortunately, the amount of RNA did not allow us to assess whether the 
microRNA content of such EV may recapitulate the one of the cells of origin, and thus propagating 
14	
	
the anti-inflammatory phenotype to target cells. However, as a support of the centenarian’s EV anti-
inflammatory activity, we report the presence of higher than expected telomeric sequences 
TTAGGG in centenarian’s EV. Indeed, extracellular telomere sequence is anti-inflammatory since 
it engages cytoplasmic DNA sensors, but exerts inhibitory effects on inflammatory/IFN response 
[51, 52]. These data strongly suggest that EV (and telomeric EV) may spread the anti-inflammatory 
setup of centenarian’s cells at systemic level, thus providing cues on the molecular mechanisms that 
taper inflamm-aging and promote longevity in humans. 
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Figure legend  
Figure 1. Reduced level of Interleukin-6 and high genetic stability in cells from centenarians. 
A. IL-6 Elisa test in aged people (old) and centenarians (cen) DF supernatants. B. Real-time PCR 
analysis of IL-6 mRNA level in old and cen DF (left panel) and Peripheral Blood Mononuclear 
cells, PBMC (right panel). C. IL-6 mRNA level in old and cen DF exposed to gamma rays (7.5Gy); 
D. IL-6 mRNA level in old and cen DF exposed to Doxorubicine (5 µM for 24h); data are presented 
as mean ± s.d.; 
Figure 2. Reduced level of DNA damage in cells from centenarians 
A. phosho-Serine139-γ-H2AX (γ-H2AX) and actin protein level in DF from young (yng), aged 
(old) and centenarian (cen). B-C. Comet assay in yng, old and cen DF under basal or 7.5Gy of 
gamma radiation exposure. D. γ-H2AX and actin protein level in yng, old and cen DF treated or 
untreated with 5 µM Doxorubicine for 24h. E. Rad51 protein level in yng, old and cen DF and 
Rad51 mRNA level in old and cen DF. Actin protein level is reported in Fig 2A. F. Confocal 
microscopy analysis of Rad51 in yng, old, cent DF at basal condition and upon exposure of 7.5Gy 
of gamma radiation G. Telomere/single copy gene ratio (T/S) in DNA from yng (n=8), old (n=4), 
cent (n=5) DF; data are presented as mean ± s.d; 
Figure 3. High level of RNAseH2C and low level of RNA:DNA hybrids in cells from 
centenarians 
A. IFN and IL-6 mRNA level in DF from young (yng), aged (old) and centenarian (cen) in a 
different set of samples respect to Figure 1B. B. TREX1 mRNA level in yng, old and cen DF. C. 
RNAseH2A-H2B-H2C mRNA level in yng, old and cen DF; RNAseH2C and actin protein level in 
yng, old and cen DF; D. Confocal microscopy analysis of RNA:DNA hybrids (S9.6 antibody) in 
yng, old and cen DF under basal or upon 7.5Gy gamma radiation exposure. E. RNASeH2C mRNA 
level in yng, old and cen DF under basal or upon 7.5Gy gamma radiation exposure. F. IL-6 mRNA 
level in yng, old and cen DF under basal or upon 7.5Gy gamma radiation exposure G. IL-6, IFN 
and RNAseH2C mRNA level in cen DF upon RNAseH2C knock-down (20 and 60 ng siRNA); data 
are presented as mean ± s.d; 
 
Figure 4. Opposite correlation of RNAseH2C locus methylation with longevity and age-
related diseases  
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A. RNAseH2C and IFN mRNA level in early passage and senescent HUVEC cells; B. RNAseH2C 
mRNA level in early and senescent (sen) lung fibroblasts; C. UCSC view (Human GRCh37/hg19) 
of the RNaseH2C CpG locus explored with EpiTYPER assay and Illumina Infinium 450K 
corresponding probes. D. Percent of methylation for each RNAseH2C CpG unit, measured in young 
(yng), aged (old) and centenarian (cen) DF. E. Percent of methylation of the Illumina Infinium 
450K CpG3 unit probe in whole-blood of people of different ages. F. Percent of methylation for 
each RNAseH2C CpG unit, in early and sen human embryonic diploid lung fibroblasts. G. Percent 
of methylation of the Illumina Infinium 450K CpG3 unit probe in normal aortic, aortic and carotid 
atherosclerotic samples (dataset GSE46394). H. Box Plot analysis of percent methylation of CpG3 
unit probe in normal and ER-positive or ER-negative breast cancer samples (dataset GSE66695); 
data are presented as mean ± s.d; 
Figure 5. Anti-inflammatory activity of extracellular vesicles from centenarians 
A. Schematic of the experimental design showing CD9+ EV isolated from young (yng), aged (old) 
and centenarian (cen) DF and administered to DF, THP1 myelomonocitic cells and MCF-7 breast 
cancer cell lines (See Supplementary Figure 2); B. IL-6 and RNAseH2C mRNA level in DF 
exposed to yng-EV, old-EV, cen-EV. C. IL-6 and RNAseH2C mRNA level in THP1 cells exposed 
to yng-EV, old-EV, cen-EV. D. IL-10, CD163, CD68 and PPARgamma mRNA level in THP1 cells 
administered with yng-EV, old-EV, cen-EV. E. Alox-15 and RXR-alpha mRNA level in THP1 
cells exposed to yng-EV, old-EV, cen-EV. F. IFN, IL-1beta and PPARalpha mRNA level in THP1 
cells administered with yng-EV, old-EV, cen-EV. G. Elisa test of Maresin1 and Resolvin D1 on 
supernatant of THP1 cells administered with yng-EV, old-EV, cen-EV under basal or upon 7.5Gy 
gamma radiation exposure. J. Real Time PCR analysis of Telomeric repeat (T/S) in EV isolated 
from of yng, old, cent DF; data are presented as mean ± s.d; 
Supplementary Figure 1  
A, B. Small RNA-seq heat-map and Principal Component Analysis (PCA) in old and cen DF (n=2 
in duplicates); C,D Relative expression level of specific microRNAs up-regulated ( C ) or down-
regulated (D) in old and cen DF; 
Supplementary Figure 2 
A. Cytofluorimetric analysis of EV isolated from supernatant of primary fibroblasts from people of 
different ages; B, MCF-7 cells exposed to yng-EV, Old-EV and cen-EV: RNAseH2C and IL6 
mRNA level; data are presented as mean ± s.d; 
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Supplementary Figure 3  
A. Snai2/Slug protein level in yng, old and cen DF and Snai2/Slug mRNA level in old and cent DF. 
Actin protein level is reported in Fig 2A. B. Snai2/Slug and Rad51 mRNA level in cen DF upon 
Slug gene knock-down; C. RNAseH2C mRNA level in cen DF upon Snai2/Slug knock-down and 
RNAseH2C mRNA level in old DF transiently transfected with Snai2/Slug encoding plasmid; data 
are presented as mean ± s.d; 
Supplementary Figure 4 
A. MS assay in MCF-7 cells administered with yng-EV, old-EV, cen-EV; B. Jagged-1 mRNA 
expression in DF administered with yng-EV, old-EV, cen-EV; data are presented as mean ± s.d;  
 
